Navigation Links
IADR and GlaxoSmithKline Consumer Healthcare announce winners of 2009 Innovation in Oral Care Awards

Alexandria, Va. The International Association for Dental Research (IADR) and GlaxoSmithKline (GSK) Consumer Healthcare today announced the 2009 winners of the annual IADR/GSK Innovation in Oral Care Awards. The three prestigious awards recognize research in innovative oral care technologies that may maintain and improve oral health and the quality of life.

In its sixth year of award support, GSK Consumer Healthcare has contributed nearly $1.4 million. Each of the three 2009 winners will receive a $75,000 unrestricted research grant, which is funded by GSK Consumer Healthcare and administered by IADR. The 2009 winners are:

  • Eric Reynolds, B.Sc., Ph.D., The University of Melbourne School of Dental Science, Australia, for "Development of Oxantel to Prevent Periodontopathogenic Biofilm Formation." Oxantel is already approved for use in humans at relatively high concentrations as a treatment for intestinal parasites. Reynolds and his team have patented its use for the treatment of periodontal diseases. Once the efficacy of Oxantel against periodontopathogenic bacterial biofilms has been demonstrated, it should be possible to develop a professional product that will result in improved oral health for persons with periodontitis.

  • Rena D'Souza, B.D.S., M.S., D.D.S., Ph.D., Baylor College of Dentistry, Texas A&M Health Science Center in Dallas, USA, for "Nanostructured Peptide Hydrogels and Stem Cells for Dentin-Pulp Complex Regeneration." This innovative research will develop and test novel peptide-based hydrogels as scaffolds to promote the differentiation of adult stem cells and the formation of dentin and pulp tissues. This biologically based endodontic therapy offers an important alternative for individuals in a clinical situation with an otherwise poor prognosis.

  • Sandra Bordin, Ph.D., The University of Washington School of Dentistry, Seattle, USA, for "Optical Coherence Tomography for Non-invasive Diagnosis of Periodontal Disorders." This proposal plans to develop miniature, high-resolution Optical Coherence Tomography (OCT) imaging needle devices to explore the validity of this bioengineering technology, which would have a near-term impact on oral health improvement by guiding biopsies and monitoring treatment response in a broad range of oral conditions, thus reducing costs of healthcare. In addition, this technology could stimulate the development/analysis of molecular studies aimed at augmenting the innate capacity of soft connective tissues to heal and regenerate.

This year, the IADR/GSK Innovation in Oral Care Awards received 28 applications from teams of researchers from around the globe. Each application was reviewed by a panel of experts under the chairmanship of Dr. Mariano Sanz, Dean, Universidad Complutense de Madrid (Spain) Dental School.

The awards will be presented during the 87th General Session & Exhibition of the IADR, to be held April 1-4, 2009, in Miami, Florida, USA.

"GSK is honored to partner with IADR to continue to offer the Innovation in Oral Care Awards to such talented investigators," said Dr. Stuart R. Smith, Vice President Global Dental Scientific and Professional Communications for GSK. "These teams have garnered ground-breaking research, and I'm confident that this research will produce innovative technologies that can be used to improve oral care."

"IADR is grateful for the tremendous contributions GSK has made to fund the prestigious Innovation in Oral Care Awards," said IADR President J.M. "Bob" ten Cate. "This awards program has received proposals from many superb investigators, and IADR is very pleased with the high aggregate standard of the applications submitted for improving oral health worldwide."


Contact: Ingrid Thomas
International & American Association for Dental Research

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
11. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine
Post Your Comments:
(Date:11/26/2015)... (PRWEB) , ... November 26, ... ... online platform for mental health and wellness consultation, has collaborated with Women’s ... holistically address their reader’s queries on topics on mental and emotional well-being ...
(Date:11/25/2015)... ... ... The holiday season is jam-packed with family dinners, parties ... is of the utmost importance. Whether you are cooking at home for the ... try this holiday season. , Turkey Croquettes ,     Ingredients: , ...
(Date:11/25/2015)... ... 25, 2015 , ... Dr. John Pierce, Medical Director at the Ageless Forever ... with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, the ... the need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro is ...
(Date:11/25/2015)... Angeles, CA (PRWEB) , ... November 25, 2015 , ... ... da Vinci surgical robot is being more and more widely heralded as a breakthrough ... assisted da Vinci method has over traditional laparoscopic surgery is that it can greatly ...
(Date:11/25/2015)... ... 25, 2015 , ... Wimbledon Health Partners, the industry leader ... Athletics Facebook page to educate the public, parents and school athletic departments ... people under the age of 25 die from sudden cardiac arrest every year. ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)...  The American Academy of Pediatrics (AAP), American ... March of Dimes cheered today,s signature into law ... of 2015 (S.799), which takes much-needed strides ... to drugs, such as opioids, and to improve ... organizations have worked together leading advocacy efforts for ...
(Date:11/25/2015)... N.Y. , Nov. 25, 2015  Henry Schein, ... and services to office-based dental, medical and animal health ... (GNYDM) Meeting the Henry Schein ConnectDental® Pavilion , ... broadest array of open solutions designed to help any ... Click here for a schedule of experts ...
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: ... and Rugen Therapeutics, a start-up  biotechnology company focused ... CNS disorders and funded by the F-Prime Biomedical ... entered into an exclusive collaboration to support the ... Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
Breaking Medicine Technology: